{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:sufentanil-citrate-injection",
  "slug": "sufentanil-citrate-injection",
  "title": "FDA shortage status: Sufentanil Citrate Injection",
  "ingredient": "Sufentanil Citrate Injection",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "SUFENTANIL CITRATE"
  ],
  "therapeutic_categories": [
    "Analgesia/Addiction",
    "Pediatric"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "EPIDURAL",
    "INTRAVENOUS"
  ],
  "package_count": 4,
  "packages": [
    {
      "package_ndc": "17478-050-01",
      "product_ndc": null,
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": null,
      "presentation": "Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/13/2026",
      "initial_posting_date": "05/03/2022",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "17478-050-02",
      "product_ndc": null,
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": null,
      "presentation": "Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/13/2026",
      "initial_posting_date": "05/03/2022",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "17478-050-05",
      "product_ndc": null,
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": null,
      "presentation": "Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/13/2026",
      "initial_posting_date": "05/03/2022",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3382-21",
      "product_ndc": "0409-3382",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "EPIDURAL",
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "05/03/2022",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Unavailable": 4
  },
  "initial_posting_date": "05/03/2022",
  "latest_source_update": "08/13/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}